Angela R. Omilian, Ph.D. - Publications

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Evolution

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Abdou Y, Attwood K, Cheng TD, Yao S, Bandera EV, Zirpoli GR, Ondracek RP, Stein L, Bshara W, Khoury T, Ambrosone CB, Omilian AR. Racial differences in CD8 T cell infiltration in breast tumors from Black and White women. Breast Cancer Research : Bcr. 22: 62. PMID 32517730 DOI: 10.1186/S13058-020-01297-4  0.371
2020 Omilian AR, Wei L, Hong CC, Bandera EV, Liu S, Khoury T, Ambrosone CB, Yao S. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women. Breast Cancer Research and Treatment. PMID 32441016 DOI: 10.1007/S10549-020-05693-4  0.38
2020 Llanos AAM, Lin Y, Chen W, Yao S, Norin J, Chekmareva MA, Omene C, Cong L, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ, Higgins M, Ambrosone CB, et al. Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype. Breast Cancer Research : Bcr. 22: 18. PMID 32046756 DOI: 10.1186/S13058-020-1256-3  0.346
2020 Bandera EV, Demissie K, Qin B, Llanos AAM, Lin Y, Xu B, Pawlish K, Plascak JJ, Tsui J, Omilian AR, McCann W, Yao S, Ambrosone CB, Hong CC. The Women's Circle of Health Follow-Up Study: a population-based longitudinal study of Black breast cancer survivors in New Jersey. Journal of Cancer Survivorship : Research and Practice. PMID 31907766 DOI: 10.1007/S11764-019-00849-8  0.345
2020 Abdou Y, Attwood K, Yao S, Cheng TD, Bandera E, Zirpoli G, Ondracek RP, Stein L, Bshara W, Khoury T, Ambrosone CB, Omilian A. Role of CD8+ T-cell infiltration in breast tumors of Black women compared to White women. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E13608  0.38
2020 Yao S, Cheng T, Elkhanany A, Yan L, Omilian A, Abrams SI, Evans S, Hong C, Qi Q, Davis W, Liu S, Bandera EV, Odunsi K, Takabe K, Khoury T, et al. Abstract IA26: Breast tumor microenvironment in black women: A distinct signature of CD8+ T-cell exhaustion Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-Ia26  0.346
2020 Abdou Y, Yao S, Attwood K, Zirpoli G, Bshara W, Ambrosone C, Omilian A. Abstract P2-10-02: Racial differences in infiltration of CD8+ T-cells in breast tumors of Black and White women Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-10-02  0.416
2019 Cheng TD, Yao S, Omilian AR, Khoury T, Buas MF, Payne-Ondracek R, Sribenja S, Bshara W, Hong CC, Bandera EV, Davis W, Higgins MJ, Ambrosone CB. FOXA1 protein expression in ER+ and ER- breast cancer in relation to parity and breastfeeding in Black and White women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31871111 DOI: 10.1158/1055-9965.Epi-19-0787  0.383
2019 Bunch B, Krishnan N, Greenspan RD, Ramakrishnan S, Attwood K, Yan L, Qi Q, Wang D, Morrison C, Omilian A, Bshara W, Pili R, Trump DL, Johnson C, Woloszynska A. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC). Cell Cycle (Georgetown, Tex.). 1-12. PMID 31318640 DOI: 10.1080/15384101.2019.1638693  0.341
2019 Mukhopadhyay UK, Oturkar CC, Adams C, Wickramasekera N, Bansal S, Medisetty R, Miller A, Swetzig WM, Silwal-Pandit L, Borresen-Dale AL, Creighton CJ, Park JH, Konduri SD, Mukhopadhyay A, Caradori A, ... Omilian A, et al. TP53 Status as a Determinant of Pro- versus Anti-tumorigenic Effects of Estrogen Receptor-beta in Breast Cancer. Journal of the National Cancer Institute. PMID 30990221 DOI: 10.1093/Jnci/Djz051  0.329
2019 Elkhanany A, Takabe K, Khoury T, Omilian A, Cheng D, Katsuta E, Davis W, Yan L, Hong C, Bandera E, Ambrosone C, Yao S. Abstract P4-06-05: PanCancer profiling reveals population difference in breast cancer immune microenvironment Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P4-06-05  0.352
2018 Purwaha P, Gu F, Piyarathna DWB, Rajendiran T, Ravindran A, Omilian AR, Jiralerspong S, Das G, Morrison C, Ambrosone C, Coarfa C, Putluri N, Sreekumar A. Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival. Metabolites. 8. PMID 30011843 DOI: 10.3390/Metabo8030041  0.377
2018 Allott EH, Geradts J, Cohen SM, Khoury T, Zirpoli GR, Bshara W, Davis W, Omilian A, Nair P, Ondracek RP, Cheng TD, Miller CR, Hwang H, Thorne LB, O'Connor S, et al. Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Research : Bcr. 20: 12. PMID 29409530 DOI: 10.1186/S13058-018-0939-5  0.361
2018 Yang Y, Attwood K, Versaggi C, Omilian A, Bshara W, Xu B, Kauffman E, Mohler J, Guru K, Li Q, George S, Basse P, Morrison C, Papanicolau-Sengos A, Kalinski P, et al. Association of high CD8+ tumor infiltrating lymphocytes at prostatectomy with improved survival of prostate cancer patients. Journal of Clinical Oncology. 36: 5068-5068. DOI: 10.1200/Jco.2018.36.15_Suppl.5068  0.331
2018 Anwer K, Matsuzaki J, Bshara W, Lugade A, Omilian A, Thaker PH, Bradley WH, Arend R, Gunderson C, Fewell J, Borys N, Musso L, Odunsi A. Abstract A76: Immunologic changes following intraperitoneal administration of a formulated IL-12 plasmid in combination with standard neoadjuvant chemo in newly diagnosed advanced stage ovarian cancer patients Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-A76  0.337
2018 Pabla S, Conroy J, Nesline M, Glenn S, Burgher B, Qin M, Andreas J, Giamo V, Lenzo FL, Omilian A, Bshara W, Papanicolau-Sengos A, Wang Y, Ernstoff M, Gardner M, et al. Abstract 5070: Chemokine expression signatures in infiltrated vs non-infiltrated tumors Cancer Research. 78: 5070-5070. DOI: 10.1158/1538-7445.Am2018-5070  0.363
2018 Luo W, Ma Y, Cortes E, Omilian A, Bshara W, Azabdaftari G, Bunch B, Johnson C, Trump D. Abstract 4625: Tumor expression of PIM kinases in renal cell carcinoma and the association with disease progression Cancer Research. 78: 4625-4625. DOI: 10.1158/1538-7445.Am2018-4625  0.362
2018 Das GM, Mukhopadhyay UK, Adams C, Wickramasekera N, Medisetty R, Bansal S, Silwal-Pandit L, Borresen-Dale A, Miller A, Sweizig WM, Omilian A, Bshara W, Mukhopadhyay A. Abstract 3748: p53 status as a determinant of functional duality of estrogen receptor beta in breast cancer: Therapeutic implications Cancer Research. 78: 3748-3748. DOI: 10.1158/1538-7445.Am2018-3748  0.396
2018 Cheng TD, Ondracek RP, Yao S, Davis W, Omilian A, Opyrchal M, Bandera EV, Higgins MJ, Ambrosone CB, Khoury T. Abstract 3242: Differences in stromal tumor-infiltrating lymphocytes in breast cancer from women of African and European ancestry after accounting for tumor characteristics Epidemiology. 78: 3242-3242. DOI: 10.1158/1538-7445.Am2018-3242  0.412
2017 Conroy JM, Pabla S, Glenn ST, Burgher B, Nesline M, Papanicolau-Sengos A, Andreas J, Giamo V, Lenzo FL, Hyland FCL, Omilian A, Bshara W, Qin M, He J, Puzanov I, et al. Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors. The Journal of Molecular Diagnostics : Jmd. PMID 29061374 DOI: 10.1016/J.Jmoldx.2017.10.001  0.329
2017 Khoury T, Zirpoli G, Cohen SM, Geradts J, Omilian A, Davis W, Bshara W, Miller R, Mathews MM, Troester M, Palmer JR, Ambrosone CB. Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods. American Journal of Clinical Pathology. 148: 108-118. PMID 28898983 DOI: 10.1093/Ajcp/Aqx053  0.38
2017 Espinal AC, Buas MF, Wang D, Cheng DT, Sucheston-Campbell L, Hu Q, Yan L, Payne-Ondracek R, Cortes E, Tang L, Gong Z, Zirpoli G, Khoury T, Yao S, Omilian A, et al. FOXA1 hypermethylation: link between parity and ER-negative breast cancer in African American women? Breast Cancer Research and Treatment. PMID 28756535 DOI: 10.1007/S10549-017-4418-Y  0.359
2017 Attwood K, Fleyshman D, Prendergast L, Paszkiewicz G, Omilian AR, Bshara W, Gurova K. Prognostic value of histone chaperone FACT subunits expression in breast cancer. Breast Cancer (Dove Medical Press). 9: 301-311. PMID 28496363 DOI: 10.2147/BCTT.S126390  0.301
2017 Grabosch S, Tseng G, Edwards RP, Lankes HA, Moore K, Odunsi K, Vlad A, Ma T, Strange M, Brozick J, Lugade A, Omilian A, Bshara W, Stuckey AR, Walker JL, et al. Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study. Gynecologic Oncology. PMID 28483269 DOI: 10.1016/J.Ygyno.2017.04.008  0.343
2017 Anwer K, Matsuzaki J, Bshara W, Lugade A, Omilian A, Thaker PH, Bradley WH, Leath CA, Gunderson CC, Fewell J, Borys N, Musso L, Odunsi K. Immunological changes following intraperitoneal administration of a formulated IL-12 plasmid in combination with standard neoadjuvant chemotherapy in patients with newly diagnosed advanced stage ovarian cancer. Journal of Clinical Oncology. 35: 156-156. DOI: 10.1200/Jco.2017.35.7_Suppl.156  0.33
2017 Davis L, Lenzo F, Ylagan L, Omilian A, Attwood K, Cance WG. FAK expression as a prognostic marker in colorectal cancer: A single institution study of 298 patients. Journal of Clinical Oncology. 35: 623-623. DOI: 10.1200/Jco.2017.35.4_Suppl.623  0.369
2016 Paluch BE, Glenn ST, Conroy JM, Papanicolau-Sengos A, Bshara W, Omilian AR, Brese E, Nesline M, Burgher B, Andreas J, Odunsi K, Eng K, He J, Qin M, Gardner M, et al. Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing. Oncotarget. PMID 27911273 DOI: 10.18632/Oncotarget.13691  0.319
2016 Zhang W, Barger CJ, Eng KH, Klinkebiel D, Link PA, Omilian A, Bshara W, Odunsi K, Karpf AR. PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget. PMID 27322684 DOI: 10.18632/Oncotarget.9977  0.323
2016 Odunsi K, Tsuji T, Eng KH, Szender JB, Matsuzaki J, Miliotto A, Gnjatic S, Bshara W, Omilian A, Morrison CD, Lele SB, Emerson RO, Desmarais C, Wang J, Liu S, et al. Prognostic effects of peripheral and tumor-infiltrating T-cell repertoire diversity in ovarian cancer. Journal of Clinical Oncology. 34: 5546-5546. DOI: 10.1200/Jco.2016.34.15_Suppl.5546  0.357
2015 Greenspan RD, Krishnan N, Morrison C, Omilian A, Bshara W, Worral A, Attwood K, Trump DL, Woloszynska-Read A, Johnson CS. Abstract LB-158: P73, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle invasive bladder cancer (MIBC) Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-158  0.34
2014 Morrison CD, Liu P, Woloszynska-Read A, Zhang J, Luo W, Qin M, Bshara W, Conroy JM, Sabatini L, Vedell P, Xiong D, Liu S, Wang J, Shen H, Li Y, ... Omilian AR, et al. Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: E672-81. PMID 24469795 DOI: 10.1073/Pnas.1313580111  0.384
2013 Wawrzyniak JA, Bianchi-Smiraglia A, Bshara W, Mannava S, Ackroyd J, Bagati A, Omilian AR, Im M, Fedtsova N, Miecznikowski JC, Moparthy KC, Zucker SN, Zhu Q, Kozlova NI, Berman AE, et al. A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion. Cell Reports. 5: 493-507. PMID 24139804 DOI: 10.1016/J.Celrep.2013.09.015  0.325
2013 Garcia H, Miecznikowski JC, Safina A, Commane M, Ruusulehto A, Kilpinen S, Leach RW, Attwood K, Li Y, Degan S, Omilian AR, Guryanova O, Papantonopoulou O, Wang J, Buck M, et al. Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers. Cell Reports. 4: 159-73. PMID 23831030 DOI: 10.1016/J.Celrep.2013.06.013  0.351
2013 Gurova KV, Garcia H, Miecznikowski J, Omilian AR, Morrison C. Level of SSRP1 in Cancer as a Prognostic Marker of Aggressive Disease American Journal of Clinical Pathology. 140: A152-A152. DOI: 10.1093/Ajcp/140.Suppl1.152  0.3
2012 Yang N, Morrison CD, Liu P, Miecznikowski J, Bshara W, Han S, Zhu Q, Omilian AR, Li X, Zhang J. TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle (Georgetown, Tex.). 11: 2922-30. PMID 22825057 DOI: 10.4161/Cc.21386  0.336
2011 Deeb KK, Luo W, Karpf AR, Omilian AR, Bshara W, Tian L, Tangrea MA, Morrison CD, Johnson CS, Trump DL. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate. Epigenetics : Official Journal of the Dna Methylation Society. 6: 994-1000. PMID 21725204 DOI: 10.4161/Epi.6.8.16536  0.322
2009 Omilian AR, Lynch M. Patterns of intraspecific DNA variation in the Daphnia nuclear genome. Genetics. 182: 325-36. PMID 19304589 DOI: 10.1534/Genetics.108.099549  0.463
2008 Omilian AR, Scofield DG, Lynch M. Intron presence-absence polymorphisms in Daphnia. Molecular Biology and Evolution. 25: 2129-39. PMID 18667441 DOI: 10.1093/Molbev/Msn164  0.459
2007 Omilian AR, Cristescu MEA, Dudycha JL, Lynch M. Erratum: Ameiotic recombination in asexual lineages of Daphnia (Proceedings of the National Academy of Sciences of the United States of America (December 5, 2006) 103, 49 (18638-18643) DOI: 10.1073/pnas.0606435103) Proceedings of the National Academy of Sciences of the United States of America. 104. DOI: 10.1073/Pnas.0611148104  0.396
2006 Omilian AR, Cristescu ME, Dudycha JL, Lynch M. Ameiotic recombination in asexual lineages of Daphnia. Proceedings of the National Academy of Sciences of the United States of America. 103: 18638-43. PMID 17121990 DOI: 10.1073/Pnas.0606435103  0.449
Show low-probability matches.